let turnover.147 Prasugrel is an alternate platelet-inhibiting pharmacologic agent
of the same class as clopidogrel that does not have these
limitations. It has been approved for use in acute coronary
syndromes,148 but no data are available on its use for stroke
prevention.
As in the case of aspirin resistance, current evidence
does not suggest the routine use of platelet function or
genetic testing for clo